Based on the available literature, COVID-19 outcomes vary from mild to severe clinical manifestations and this may reflect different airway levels of ACE 2 and TMPRSS2, which are indispensable for virus entry into the host cell. This evidence concerns the gene TMPRSS2 and COVID-19.